Page last updated: 2024-10-26

diethylcarbamazine and Corneal Opacity

diethylcarbamazine has been researched along with Corneal Opacity in 4 studies

Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.

Corneal Opacity: Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.

Research Excerpts

ExcerptRelevanceReference
"We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial."9.05Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. ( Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT, 1985)
"We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial."5.05Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. ( Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT, 1985)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sowa, J1
Sowa, SC1
Donnelly, JJ1
Sakla, AA1
Hill, DE1
Lok, JB1
Khatami, M1
Rockey, JH1
Greene, BM1
Taylor, HR1
Cupp, EW1
Murphy, RP1
White, AT1
Aziz, MA1
Schulz-Key, H1
D'Anna, SA1
Newland, HS1
Goldschmidt, LP1
Tejan-Jalloh, II1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis[NCT04188301]Phase 2154 participants (Actual)Interventional2019-12-06Completed
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis[NCT06070116]Phase 2300 participants (Anticipated)Interventional2024-01-15Not yet recruiting
Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis[NCT03517462]231 participants (Actual)Interventional2018-08-06Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Effectiveness of Killing Adult Female Worms

The effectiveness of three treatment regimens for killing adult female O. volvulus worms based on the percentage of all adult female worms in nodules that are alive 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment

InterventionFemale worms in nodule (Count of Units)
IVM + ALB127
IDA x 1 Dose142
IDA x 3 Doses159

Percentage of Worms Killed Across Study Arms

The effect of three treatment regimens for killing adult female O. volvulus worms will be compared based on the percentage of all adult female worms in nodules that are alive with embryos in the uterus 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.

InterventionFemale worms in nodules (Count of Units)
IVM + ALB127
IDA x 1 Dose142
IDA x 3 Doses159

Percentage of Worms Sterilized Across Study Arms

The effect of three treatment regimens for sterilizing adult female O. volvulus worms will be compared based on the percentage of all adult female worms that are fertile in the nodules 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.

InterventionFemale worms with intact uterus (Count of Units)
IVM + ALB41
IDA x 1 Dose40
IDA x 3 Doses34

Rates of Ocular Adverse Events (Any Grade) by Treatment Group

Rates of ocular adverse events of any grade within 3 months will be compared by treatment group. (NCT04188301)
Timeframe: within 3 months of treatment with IDA

InterventionParticipants (Count of Participants)
IVM + ALB4
IDA x 1 Dose4
IDA x 3 Doses3

Rates of SAEs by Treatment Group in Those With Intraocular Microfilariae Just Prior to Treatment With IDA

Rates of adverse events grade 3 or higher that occur within 7 days of treatment in the subset of participants who have intraocular microfilariae just prior to treatment with IDA will be compared by treatment group. (NCT04188301)
Timeframe: within 7 days following end of treatment

InterventionParticipants (Count of Participants)
IVM + ALB0
IDA x 1 Dose0
IDA x 3 Doses0

Rates of Severe Adverse Events (SAEs) Across Study Arms

Rates of severe adverse events (grade 3 or higher) following 1-day or 3-day triple drug treatment will be compared against those of the comparator regimen of 1 day of IVM/ALB. (NCT04188301)
Timeframe: Within 7 days following end of treatment

InterventionParticipants (Count of Participants)
IVM + ALB0
IDA x 1 Dose0
IDA x 3 Doses0

Effectiveness for Preventing Reappearance of Microfilariae in the Skin by Skin Snips

The effectiveness of three treatment regimens for preventing reappearance of microfilariae in the skin as determined by skin snips at 12 and 18 months after treatment will be compared by treatment arm. Measured by the presence of microfilariae in skin snips. (NCT04188301)
Timeframe: Baseline, 12 months, and 18 months following treatment

,,
InterventionCount of microfilarae+ participants (Number)
BaselineMonth 12Month 18
IDA x 1 Dose62115
IDA x 3 Doses02117
IVM + ALB72320

Effectiveness of Clearing Microfilariae From Skin by Skin Snips

The effectiveness of three treatment regimens for complete clearance of microfilariae from the skin as determined by skin snips at 3, 12, and 18 months after treatment with IDA will be compared by treatment arm. (NCT04188301)
Timeframe: Baseline, 3 months, 12 months, & 18 months following treatment.

,,
InterventionCount of Skin Microfilaria (Geometric Mean)
BaselineMonth 3Month 12Month 18
IDA x 1 Dose1.732.59.0
IDA x 3 DosesNA2.14.78.6
IVM + ALB3.11.94.97.0

Trials

2 trials available for diethylcarbamazine and Corneal Opacity

ArticleYear
Long-term treatment of onchocerciasis in children with low doses of diethylcarbamazine.
    Annals of tropical medicine and parasitology, 1978, Volume: 72, Issue:1

    Topics: Child; Clinical Trials as Topic; Corneal Opacity; Diethylcarbamazine; Eye; Ghana; Humans; Long-Term

1978
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3

    Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth

1985

Other Studies

2 other studies available for diethylcarbamazine and Corneal Opacity

ArticleYear
Effect of diethylcarbamazine citrate and anti-inflammatory drugs on experimental onchocercal punctate keratitis.
    Ophthalmic research, 1987, Volume: 19, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Cornea; Corneal Opacity; Corneal Stroma; Diethylcarbamazine; Fema

1987
Some observations on onchocerciasis in the Koinadugu District of Sierra Leone.
    Tropical doctor, 1974, Volume: 4, Issue:1

    Topics: Corneal Opacity; Deafness; Diethylcarbamazine; Hernia, Inguinal; Humans; Keratitis; Male; Onchocerci

1974